STING1 and rheumatoid arthritis: Additionally, nanodrugs, specifically Nanomedicine-in-hydrogel, can be used as a targeted approach to inhibit the cGAS-STING pathway in RA, aiming to induce systemic immune suppression and restrain disease progression.